Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K

[Medulloblastoma. Pathology].

A Siegfried1, M-B Delisle2

  • 1Département d'anatomie et cytologie pathologiques, institut universitaire du cancer, oncopole, 31059 Toulouse, France; Neuropathologie, laboratoire universitaire d'anatomie et cytologie pathologiques, université Toulouse III-Paul-Sabatier, CHU de Toulouse, 31059 Toulouse, France.

Neuro-Chirurgie
|April 29, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral tympanic myxoma: A CARE case report.

European annals of otorhinolaryngology, head and neck diseases·2022
Same author

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation.

Journal of neuro-oncology·2020
Same author

Acute ischemic lesions in cerebral amyloid angiopathy-related inflammation.

Revue neurologique·2019
Same author

Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma.

Familial cancer·2018
Same author

Research participation among state and local public health emergency preparedness and response programs.

Public health·2018
Same author

A French retrospective study on clinical outcome in 102 choroid plexus tumors in children.

Journal of neuro-oncology·2017
Same journal

Complications of lumbar anterior retroperitoneal approach: What are the risks and their factors?

Neuro-Chirurgie·2026
Same journal

Full-endoscopic uniportal wiltse paraspinal approach with inferior foraminal docking for extraforaminal lumbar disc herniation and foraminal stenosis: technical note and preliminary clinical outcomes.

Neuro-Chirurgie·2026
Same journal

Beyond "Time to Surgery": a structured evidence review and multi-clock framework for emergency cranial neurosurgery.

Neuro-Chirurgie·2026
Same journal

Clinical predictors of overall survival in very elderly patients with spinal osteosarcoma: an analysis of the surveillance, epidemiology, and end results database.

Neuro-Chirurgie·2026
Same journal

Advances in tailored intraparenchymal delivery of regenerative medicine for spinal cord injury: a review of preclinical studies and clinical trials.

Neuro-Chirurgie·2026
Same journal

The renal involvement during lateral lumbar interbody fusion: a radioanatomical study for surgical risk stratification.

Neuro-Chirurgie·2026
See all related articles

This review details medulloblastoma classification, integrating molecular and histopathological data for improved diagnosis and prognosis. Understanding these subtypes is crucial for effective childhood brain tumor treatment.

Area of Science:

  • Pediatric neuro-oncology
  • Cancer genomics and molecular pathology
  • Neuropathology and tumor classification

Background:

  • Medulloblastomas are pediatric embryonal neuroepithelial tumors primarily affecting the cerebellum and brain stem.
  • Current treatment relies on stratifications based on postoperative data, histopathology, tumor extension, and MYC/NMYC amplification.
  • Recent advancements in molecular biology have introduced new genetic subtypes, integrated into the WHO-2016 classification.

Purpose of the Study:

  • To review the latest WHO-2016 classification of medulloblastomas, emphasizing genetic subtypes (WNT, SHH, non-WNT/non-SHH including subgroups 3 and 4).
  • To detail the contribution of immunohistochemistry in defining these molecular groups.
  • To compare histopathological groups with the WHO-2007 classification and molecular data, highlighting discordances and age-related correlations.
Keywords:
Biologie moléculaireClassification OMSHistopathologieHistopathologyMedulloblastomaMolecular biologyMédulloblastomeWHO classification

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.8K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.6K

Related Experiment Videos

Last Updated: Feb 11, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.8K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.6K

Main Methods:

  • Review of recent molecular biology studies utilizing sequencing, transcriptomic, and methylomic data.
  • Analysis of immunohistochemistry's role in classifying medulloblastoma subtypes.
  • Comparison of histopathological classifications (classic, desmoplastic/nodular, extensive nodularity, large cell/anaplastic) with molecular data and previous WHO classifications.

Main Results:

  • The WHO-2016 classification integrates genetic subtypes (WNT, SHH, non-WNT/non-SHH) with TP53 mutation status.
  • Genetic and histopathological classifications are not always concordant, with varying correlations based on patient age.
  • Differential diagnosis with other embryonal tumors and gliomas is discussed, noting ongoing classification efforts.

Conclusions:

  • The evolution of medulloblastoma classification necessitates structured approaches like histopathological review (RENOCLIP) and molecular biology platforms.
  • Accurate classification based on integrated molecular and histopathological data is vital for improving medulloblastoma management and prognosis.
  • Understanding the distinct genetic and histopathological subgroups is essential for tailoring treatment strategies in pediatric neuro-oncology.